During the past decade, Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive" are "Metastatic Colorectal Cancer" (2 trials), "Colorectal Cancer" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Esophageal Squamous Cell Carcinoma (ESCC)" (1 trials) and "Refractory Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive" in a lesser frequency.

Most popular intervention types in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Capecitabine" (2 trials), "Placebo" (2 trials), "Tislelizumab" (2 trials) and "Bevacizumab control" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".